University of Utah
Pediatric Hematology-Oncology fellowship · Salt Lake City, UT · University of Utah programs · Program website
Pediatrics residency here · Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Emergency Medicine · Pediatric Gastroenterology · Pediatric Infectious Diseases · Pediatric Endocrinology · Pediatric Nephrology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Utah's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at University of Utahshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from University of Utah and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at University of Utah
Papers in the window; each links to the list on OpenAlex.
- Cancer survivorship and care 122
- Multiple Myeloma Research and Treatments 119
- Cancer Immunotherapy and Biomarkers 116
- CAR-T cell therapy research 116
- Acute Myeloid Leukemia Research 100
- Colorectal Cancer Screening and Detection 100
- Cutaneous Melanoma Detection and Management 99
- Hematopoietic Stem Cell Transplantation 92
Most cited at University of Utah since 2024
All pediatric hematology-oncology papers there on OpenAlex
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 183
- Platelet TransfusionRyan A. Metcalf et al. · JAMA · 2025 · PubMed · cited 155
- Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power et al. · European Heart Journal · 2025 · PubMed · cited 102
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta et al. · New England Journal of Medicine · 2024 · PubMed · cited 253
- Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation studySwaminathan P. Iyer et al. · The Lancet Oncology · 2024 · PubMed · cited 93
- Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myelomaSurbhi Sidana et al. · Blood · 2024 · PubMed · cited 162
- Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)Ghayas C. Issa et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 272
- CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell CarcinomaSumanta Kumar Pal et al. · Cancer Discovery · 2024 · PubMed · cited 181
- Supramolecular Coordination Complexes for Synergistic Cancer TherapyYang Li et al. · Accounts of Chemical Research · 2024 · PubMed · cited 108
- Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P. Shah et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 158
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-utah-peds-heme-onc"><img src="https://openprograms.org/programs/university-utah-peds-heme-onc/badge.svg" alt="University of Utah Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.